Skip to content

Predictors of employment status and work absenteeism in relapsing-remitting Multiple Sclerosis

Predictors of employment status and work absenteeism in relapsing-remitting Multiple Sclerosis - MS Employment study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47448
Enrollment
350
Registered
2014-02-12
Start date
2014-04-08
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS Multiple Sclerosis

Interventions

None listed

Sponsors

Nationaal MS Fonds
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients with a diagnosis of relapsing-remitting Multiple Sclerosis according to the McDonald criteria 2010 and healthy controls not diagnosed with any neurological, psychiatric or other chronic disorder -18 years or older -currently employed or within 3 years since their last employment

Exclusion criteria

Exclusion criteria: -co morbid psychiatric or neurological disorders -substance abuse -MS relapse within 1 month prior to the study visit -unable to speak and/or read Dutch -neurological impairment that might interfere with cognitive testing (e.g. upper limb weakness, dysarthria, vision worse than 20/70)

Design outcomes

Primary

MeasureTime frame
The outcome variables include changes in employment status (i.e. stable versus deteriorated) and work absenteeism (i.e. days missed from work during a specified period) from baseline to endpoint

Secondary

MeasureTime frame
The secondary study parameters include the predictor variables, i.e. cognitive performance and cognitive complaints, physical ability, psychological functioning (i.e. anxiety, depression, psychosocial stress, quality of life, fatigue, empathy, personality traits and coping strategies), gene set data, polygenetic risk score, and type of immunomodulatory treatment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)